Based on the current movement in the crypto market, analysts believe that the crypto bull run will be back sooner than expected. Hedera (HBAR) and Injective Protocol (INJ) are among the top tokens in the crypto market.
With Hedera (HBAR) and Injective Protocol (INJ) witnessing a downtrend lately, holders are shifting their focus to the Raffle Coin (RAFF), for which analysts have projected a 50x return in the coming months. The Raffle Coin (RAFF), which is in stage 1 of the presale, is seen as an innovative project that will bring excitement and profitability in the crypto space.
Hedera (HBAR) Price Shows Positive Outlook in the Past Month
Hedera (HBAR) is one of the crypto coins that witnessed bullish momentum in the past months before the latest market correction. Based on CoinMarktCap data, the Hedera (HBAR) price has increased by 75% in the year-to-date price metric. The Hedera (HBAR) token has also gained a slight 4% in the past month. However, despite the great performance of Hedera (HBAR) in the past weeks, it is still far from its ATH of $0.57, achieved in September 2021.
Meanwhile, Hedera (HBAR) has been in a downtrend in the past week as seen from the 4% decline in the weekly price chart. The declining Hedera (HBAR) trading volume has led to ripples in the market with some holders jumping ship to the Raffle Coin (RAFF) ongoing presale. While analysts remain optimistic on the long-term prospects of the token, Hedera (HBAR) will need massive buyer activity to recover.
Injective Protocol (INJ) Price Slumps, as Investors Eye Raffle Coin (RAFF)
Despite showing year-to-date growth of 776%, Injective Protocol (INJ) has slipped to bear pressure in recent days. Based on CoinMarktCap data, the Injective Protocol (INJ) coin declined by 16% in the past week. This uninspiring performance of the Injective Protocol (INJ) is why many token holders are shifting their focus to the Raffle Coin (RAFF) presale which analysts have projected over 50x ROI in the coming months.
Also, all key market indices of the injective protocol (INJ), such as trading volume and market cap, are all negative. This has led to investors taking cautionary measures before buying more Injective Protocol (INJ) tokens. Although crypto experts project a rise in the price of Injective Protocol (INJ) in the near future, holders are already considering other crypto alternatives such as the Raffle Coin (RAFF) which is set to disrupt the market with its novel idea.
Raffle Coin (RAFF) Presale Lures Hedera (HBAR) and Injective Protocol (INJ) Investors
The Raffle Coin (RAFF) platform is a revolutionary crypto project that allows users to win prizes, including cryptos, vacations, luxury cars and more. The Raffle Coin (RAFF) is a decentralized platform that leverages blockchain technology to make all transactions on its platform safe and transparent. To ensure stability, the smart contract has been audited and the team tokens will be locked for two years while liquidity will be locked for life.
Presently at Stage 1 of the presale, the Raffle Coin (RAFF) is sold for just $0.020. The cheap price point makes now the best entry point. There are a lot of utilities in the Raffle Coin (RAFF) ecosystem. There is a swap service, a revenue-sharing model, and a reward program which are all beneficial to users. With all these unique features, Raffle Coin (RAFF) may very well end up becoming a future blue chip crypto. That makes now the best time to invest in the project.
Find out more about the Raffle Coin (RAFF) presale by visiting the website here
Disclaimer: This is a paid release. The statements, views and opinions expressed in this column are solely those of the content provider and do not necessarily represent those of NewsBTC. NewsBTC does not guarantee the accuracy or timeliness of information available in such content. Do your research and invest at your own risk.
